Stability Testing in Pharmaceutical Development and Manufacturing

14 - 15 May 2013, London, United Kingdom

This course has been updated to reflect the recent changes in the pharmaceutical stability testing world.

The new course content will provide a comprehensive update on current trends which offer substantial potential savings in time and resources in a traditionally costly testing area. It will include opportunities for review of specific participant problems

The course will cover:
Recent regulatory changes affecting stability including:
• The implications of implementation of ICH Q7, Q8, Q9, Q10 and Q11 for stability testing
• Changes to European GMP guidance with impact on stability testing including Annexe updates affecting product development, outsourcing and application of Quality Risk Management (QRM)
• Product Quality Reviews and the interpretation of stability data.

Recent scientific developments with implications for stability, with a particular focus on cost reduction, shortening of development timelines, and improvements on existing interpretation systems.
• ASAP - using short term high stress testing to get accurate predictions of shelf life with a high degree of confidence – Freethink Technologies' ASAPprime®
• Low level impurities and their impact on product stability
• Manipulation of tablet internal pH to improve product stability

The course is designed for people working in:
• Analytical and Product Development
• Analytical Chemistry
• Stability Testing
• Formulation Development
• Regulatory Affairs
• Pharmaceutical & Biopharmaceutical Production
• Quality Control and Quality Assurance
• Technical Operations
Window Conference Venue

Window Conference Venue, 14 Windsor Street, Islington, London, N1 8QG, United Kingdom

Organised by
Contact information
Showing all upcoming events
Start Date
End Date
Subject area
Event type


E-mail Enquiry